CanSino Coronavirus Vaccine Shows Promise in Mid-Stage Study
A researcher fills a test tube with cells to be infected with Covid-19 during coronavirus vaccine research work in Lille, France. (Photographer: Adrienne Surprenant/Bloomberg)

CanSino Coronavirus Vaccine Shows Promise in Mid-Stage Study

(Bloomberg) -- CanSino Biologics Inc.’s experimental coronavirus vaccine showed promising results in a mid-stage clinical study, paving the way for the next phase of tests as the Chinese company jo...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.